Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G4A | P47712 | 20/20 | 0.89 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Efipladib SCHEMBL29586714 | 0.94 | PLA2G4A (1.00) | PLA2G4A | |
| Efipladib SCHEMBL1500831 | 0.94 | PLA2G4A (1.00) | PLA2G4A | |
| SCHEMBL1500847 | 0.92 | PLA2G4A (0.88) | PLA2G4A | |
| SCHEMBL82559 | 0.92 | PLA2G4A (0.88) | PLA2G4A | |
| SCHEMBL3549115 | 0.92 | PLA2G4A (0.87) | PLA2G4A | |
| SCHEMBL29862372 | 0.91 | PLA2G4A (1.00) | PLA2G4A | |
| SCHEMBL1501417 | 0.91 | PLA2G4A (1.00) | PLA2G4A | |
| SCHEMBL3552380 | 0.91 | PLA2G4A (0.86) | PLA2G4A | |
| SCHEMBL3541673 | 0.91 | PLA2G4A (0.85) | PLA2G4A | |
| SCHEMBL1500752 | 0.90 | PLA2G4A (1.00) | PLA2G4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080177085-A1 | Process for the Synthesis of a CPLA2 Inhibitor | DEHNHARDT CHRISTOPH M | 2008-07-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080177085-A1 | Process for the Synthesis of a CPLA2 Inhibitor | PLAA, PLA2G4A, PLA2G12A | PLA2G4A 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.